135 related articles for article (PubMed ID: 36620877)
1. Sestrin2 mediates FOXM1 expression to block the EMT process in non-small cell lung cancer through the AMPK/YAP pathway.
Wang YL; Wang Q; Li H; Wang CC; Ma YL; Han Z
Neoplasma; 2023 Feb; 70(1):46-57. PubMed ID: 36620877
[TBL] [Abstract][Full Text] [Related]
2. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
[TBL] [Abstract][Full Text] [Related]
3. FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC.
Kong FF; Zhu YL; Yuan HH; Wang JY; Zhao M; Gong XD; Liu F; Zhang WY; Wang CR; Jiang B
Oncol Res; 2014; 22(1):29-37. PubMed ID: 25700356
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
5. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
[TBL] [Abstract][Full Text] [Related]
6. Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation.
Zhang H; Zhou Q; Shen W
J Orthop Surg Res; 2022 Jul; 17(1):344. PubMed ID: 35799265
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
8. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
9. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
Chen W; Zhang Y; Fang Z; Qi W; Xu Y
Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
[TBL] [Abstract][Full Text] [Related]
10. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Liu MX; Zhou KC; Cao Y
Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
[TBL] [Abstract][Full Text] [Related]
12. Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis.
Wei H; Li L; Zhang H; Xu F; Chen L; Che G; Wang Y
Cell Cycle; 2021 Jan; 20(2):166-178. PubMed ID: 33413028
[TBL] [Abstract][Full Text] [Related]
13. Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis.
Jin D; Guo J; Wu Y; Chen W; Du J; Yang L; Wang X; Gong K; Dai J; Miao S; Li X; Su G
J Exp Clin Cancer Res; 2020 Jan; 39(1):6. PubMed ID: 31906986
[TBL] [Abstract][Full Text] [Related]
14. TM4SF1 facilitates non-small cell lung cancer progression through regulating YAP-TEAD pathway.
Fu XY; Zhou WB; Xu J
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1829-1840. PubMed ID: 32141552
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
Guo R; Hu T; Liu Y; He Y; Cao Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
Pang L; Cheng Y; Zou S; Song J
Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
[TBL] [Abstract][Full Text] [Related]
17. Targeting TRIM9 by miR-218-5p Restricts Cell Proliferation and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Wang Z; Wang B; Wang K
Ann Clin Lab Sci; 2023 Jan; 53(1):106-115. PubMed ID: 36889762
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
20. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
Li J; Wang Y; Luo J; Fu Z; Ying J; Yu Y; Yu W
FEBS Lett; 2012 Oct; 586(20):3761-5. PubMed ID: 23010597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]